Investigation of biology & outcomes of frailty in emergency laparotomy

  • Research type

    Research Study

  • Full title

    An investigation of frailty markers and outcomes in patients requiring emergency laparotomy

  • IRAS ID

    293392

  • Contact name

    Susan Moug

  • Contact email

    susan.moug@ggc.scot.nhs.uk

  • Sponsor organisation

    NHS Greater Glasgow and Clyde

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    Emergency laparotomy (EmLAP; abdominal surgery) is one of the most common operations performed in the UK (30 000/ year) and is usually on older adults (>65 years). Unfortunately, they carry the highest risk of complications, including death, especially if frail before surgery. Frailty is a reduction in physiological reserve and although prevalent in older adults (20% of EmLAPs), it exists in younger adults too (16% of emergency surgical admissions), a number that is likely to increase post-COVID pandemic. This is compounded by the physiological stress that EmLAP places on these patients that can make frail patients frailer and previously well patients frail. (defined as surgical frailty). Therefore, understanding the mechanisms of frailty is paramount to lead to improvements in outcomes for EmLAP patients.
    We will explore the biology of frailty and its influence on patient outcomes on EmLAP patients that are >40 years from a busy district general hospital (>200 EmLaps per year). We will achieve this by 2 planned workstreams.
    Workstream 1 will prospectively collect frailty markers before, during and after EmLAP: (a) frailty metabolomics using blood serum/ plasma (b) physical frailty markers: muscle bulk (sarcopenia) on CT (80% of EmLAP patients have at least one CT) and nutrition (Malnutrition Universal Screening Tool; MUST score) (c) Frailty Score/ Questionnaires: Clinical Frailty Score (1 to 9) where 1 is fit and 9 is extremely frail (d) cognitive marker: Abbreviated mental test (AMT). Results from pre-operative, post- operative day 1 and day 7/ discharge day will be compared to post- operative outcomes (day 30 and day 90).
    Workstream 2 will focus on defining what matters to EmLAP patients. This will be a mixed-methods approach: systematic review; PPI day; Quality of life (QoL) questionnaires. The questionnaires will be timed with WorkStream 1 to allow changes in QoL to be defined.

  • REC name

    Scotland A: Adults with Incapacity only

  • REC reference

    22/SS/0021

  • Date of REC Opinion

    6 May 2022

  • REC opinion

    Favourable Opinion